An aqueous Ophthalmic Solution that includes diquafosol or a Salt thereof in a concentration between 0.1 and 10% (W / V) and a compound chlorhexidine in a concentration of between 0.0001 to 0.1% (W / V).Claim 1: an aqueous Ophthalmic Solution which comprises diquafosol or a Salt thereof in a concentration of 0.1% and 10% (W / V) and a compound chlorhexidine in a concentration of between 0.0001% and 0.1% (W / V).Claim 2: aqueous Ophthalmic Solution according to claim 1, wherein the compound is chlorhexidine chlorhexidine gluconate. Claim 8: aqueous Ophthalmic Solution according to any one of claims 1 to 6, wherein the concentration of diquafosol or the Salt of this in Ophthalmic Solution is 3% (W / V).Claim 9: aqueous Ophthalmic Solution according to any one of claims 1 to 8, characterized in that it also comprises a chelating Agent. Claim: The 10 aqueous Ophthalmic Solution according according to claim 1, characterized in that the chelating Agent is the Ethylenediaminetetraacetic acid or a Salt thereof.Claim 18: a method for Preventing a decrease in the proportion of remaining a chlorhexidine compound in an aqueous Ophthalmic Solution which comprises between 0.1% and 10% (W / V) diquafosol or a Salt of this compound and use of chlorhexidine, characterized in that it comprises a Compound chlorhexidine in a concentration of between 0.0001% and 0.005% (W / V) for preparing an aqueous Ophthalmic Solution.Claim 19: a method for Stabilizing a chlorhexidine compound in an aqueous Ophthalmic Solution which comprises between 0.1% and 10% (W / V) diquafosol or a Salt of this Compound chlorhexidine, characterized in that it comprises Controlling the concentration of the compound of clorhex Idina so that exceed 0.001% (W / V) and less than 0.1% (W / V).Una solución oftálmica acuosa que incluye dicuafosol o una sal del mismo en una concentración de entre 0,1 y 10% (p/v) y un compuesto de clorhexidina en una concentración de entre 0,0001 y 0,1% (p/v). Reivindicación 1:
